Corvite Fe By Vertical Pharmaceuticals Overview & Drug Interactions

Check For Interactions With Corvite Fe

Supplement: Corvite Fe by Vertical Pharmaceuticals

Corvite Fe Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Corvite Fe by Vertical Pharmaceuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 30
UPC/BARCODE 368025-060-301

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Total Carbohydrates
1 Gram(s)
Carbohydrate 1% 1%
Vitamin C
160 mg
Vitamin C 178% 133%
Vitamin D
25 mcg
Vitamin D 125% 167%
Vitamin B6
10 mg
Vitamin B6 588% 500%
Folate
1667 mcg DFE
Folate 417% 278%
Folic Acid
700 mcg
Folate
Quatrefolic
300 mcg
5-methyltetrahydrofolate glucosamine
Vitamin B12
15 mcg
Vitamin B12 625% 536%
Iron
150 mg
Iron 833% 556%
Magnesium
15 mg
Magnesium 4% 4%
Zinc
25 mg
Zinc 227% 192%
Calcium Threonate
5 mg
Calcium -- --

Other Ingredients:
Microcrystalline Cellulose
Dicalcium Phosphate
Starch, Pregelatinized
Hydroxypropylmethylcellulose
Polyvinyl Alcohol
FD&C Red #40 Lake
Glycerol Triacetate
Titanium Dioxide
Talc
FD&C Yellow #6 Lake
FD&C Blue #2 Lake
Croscarmellose Sodium
Magnesium Stearate
Silicon Dioxide
fumed Silica


Label Statments:


FDA Statement of Identity
- Iron Supplement
Formula
- Multivitamin/multimineral with Quatrefolic
Formulation
- Gluten, lactose and sugar free
- Vegetarian friendly
- Corvite Fe is a professionally prescribed hematinic multivitamin/multi mineral dietary supplement wed to improve the nutrition status of patients with iron deficiency; this includes women prior to conception throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.
General Statements
- Vertical Pharmaceuticals
- Description Corvite Fe are red, oval bisected tablet imprinted with "VP060." How Supplied Corvite Fe is available in bottles of 30 tablets.
- Lift here for full product information
Storage
- Storage Store at controlled room temperature 15 degrees-30 degrees C (59 degrees-86 degrees F) [See USP]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined by the USP using a child-resistant closure.
Precautions
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- Contraindications Corvite Fe should not be used by patients with a known hypersensitivity to any of the listed ingredients. All iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias. Precautions General: Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with Corvite Fe. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. Folic Acid: Folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.
- Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
- The patient's medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
- Pediatric Use: Safety and effectiveness in pediatric population have not been established.
- Drug Interactions There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., aspirin, heparin, clopidogrel).
- Adverse Reactions Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain which are usually transient. Overdosage The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.
- Keep out of reach of children.
- Call your doctor about side effects. To report side effects, call Vertical Pharmaceuticals at 1-877-95-VERTI (1-877-958-3784) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Brand IP Statement(s)
- Quatrefolic is a registered trademark of Gnosis, SpA. U.S. Patent No. 7,947,662. TRAACS is registered trademark of Albion International, Inc. Malate covered by U.S. Patent No, 6,706,904; Chelate covered by U.S. Patent No. 7,838,042.
Suggested/Recommended/Usage/Directions
- Direction for use Take one tablet by mouth daily or as directed by a physician.

Brand Information

See all products by this brand

To report side effects, call Vertical Pharmaceuticals at
Phone Number 1-877-958-3784
Distributed by
Name Vertical Pharmaceuticals, LLC
City Bridgewater
State NJ
ZipCode 08807
Phone Number 1-866-600-4799
Web Address www.verticalpharma.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.